[US Stock Market Volatility] BillionToOne Plunged on October 6: Insider Selling, Valuation Adjustment, and Medicare Payment Risk

BillionToOne October 6 Major Decline Analysis

Keywords: Insider selling, valuation adjustment, medical insurance payment risk

1. On September 28, 2026, the company's Chairman and CEO sold 10,999 shares, cashing out approximately 1.327 million USD; previously on September 14, they sold 30,331 shares, increasing short-term stock supply.

2. On September 22, 2026, the company's share price rose 12% in a single day without any announcement. The institutional average target price is around 120 USD, with limited upside potential and increasing valuation pressure at high levels.

3. On October 3, 2026, analysis cited the proposed 2027 US Medicare Fee Schedule, indicating that some testing fees may face an annual reduction of up to approximately 15%, with reimbursement pressure on fetal antigen testing and non-invasive prenatal testing.

(Disclaimer: This content is generated by AI technology based on publicly available information for summary purposes only and does not constitute investment advice.)